Table: Daito - 6-MTH group results

Daito Pharmaceutical

13/01/2023 06:00

Jan 13 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Nov 30, 2022        Nov 30, 2021     May 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               23.37               22.46            44.00    
                   (+4.0 pct)                           (+1.2 pct)  
  Operating            2.83                3.88             4.50    
                   (-27.1 pct)         (+10.4 pct)      (-31.3 pct) 
  Recurring            2.75                3.98             4.60    
                   (-30.9 pct)         (+12.0 pct)      (-31.6 pct) 
  Net                  1.76                2.78             3.20    
                   (-36.5 pct)         (+14.6 pct)      (-31.5 pct) 
  EPS              122.46 yen          202.05 yen       222.72 yen  
  EPS Diluted      122.24 yen                                       
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div           30.00 yen           25.00 yen                   
  -Q4 div                               35.00 yen        30.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T